摘要
中药经典名方是中医药传统知识的重要组成部分,是不可或缺的知识产权形式。然而现代专利制度下中药经典名方存在诸如申请量少授权率低、研发创新不足、专利权流失、侵权认定困难等问题。针对这些问题,并结合中药自身特点,笔者提出构建经典名方创新研发体系、健全经典名方专利管理体系、促进中医药专利国际化认证、进攻性与防御性策略相结合等建议。
The classical prescriptions of traditional Chinese medicine (TCM) are an important part of TCM knowledge and an indispensable form of intellectual property. However, under the modern patent system, classical TCM prescriptions have problems such as low application and authorization rates, less research & development (R&D) innovation, loss of patent rights, and difficulty in identifying infringement. In response to these problems and considering the characteristics of TCM, we propose to build a classic innovative R&D system, to establish the patent management system of classical prescriptions, to promote the internationalization of Chinese medicine patents, and to combine aggressive and defensive strategies.
作者
姚峥嵘
王丹丹
王艳翚
YAO Zhengrong;WANG Dandan;WANG Yanhui(School of Health Economics and Management,Nanjing University of Chinese Medicine,Nanjing 210046,China)
出处
《医学争鸣》
CAS
2019年第5期13-17,共5页
Negative
基金
教育部人文社会科学研究规划基金(16YJA820022)
关键词
中医药
经典名方
专利保护
traditional Chinese medicine
classical prescription
patent protection